Total Cases


Total Deaths


Total Recovered


Total Active Cases


New Deaths


New Cases

via theloadstar04/14/2021

New state-of-the-art 50,000sq m logistics building at Brussels Airport -

A new state-of-the-art 50,000-m² logistics building at Brussels Airport After two years of construction work, a new logistics building for the handling of goods was officially opened in the logistics area at Brussels Airport. This building which provides large refrigerated storage spaces and offers direct airside access, henceforth accommodates three first-class logistics companies: Kuehne+Nagel, Worldwide Flight Services and Expeditors. Brussels Airport boasts an essential logistics platform for the import and export ...

via bmj04/14/2021

Covid-19: How AstraZeneca lost the vaccine PR war - The BMJ

AstraZeneca’s covid-19 vaccine has rarely been out of the news—and the headlines show no signs of abating. Jacqui Wise explains how miscommunication and politics created a nightmare for the company and the global vaccination effort Hailed as a “vaccine for the world” with its low price and easy storage requirements, AstraZeneca’s vaccine candidate has faced a string of setbacks in 2021 with questions over effectiveness, possible side effects, and long running disputes about supplies. It’s not clear why the Anglo-Swedish company and its vaccine have been singled out for so much criticism, but poor communication seems to be at the heart of the problem. Martin McKee, professor of European public health at the London School of Hygiene & Tropical Medicine, says, “This is a company that has taken an innovative product to market in record time but has mishandled communications at every step. Trust and confidence are so important for vaccines—you can’t divorce the two.” AstraZeneca’s latest crisis is possibly also its biggest so far. Its vaccine has been linked to thrombosis, as well as a rare type of blood clot in the brain called cerebral venous sinus thrombosis (CVST), with a number of episodes in younger women. The vaccine was authorised for use in Europe at the end of January and started to be used more widely in February. On 7 March Austrian authorities announced that they were investigating a death that was possibly vaccine related. A few days later Denmark and Norway were investigating reports of blood clots and a death after vaccination. On 15 March Germany suspended its use of the vaccine, followed swiftly by several other countries.12 The European Medicines Agency (EMA) and the World Health Organization say that the vaccine’s benefits outweigh any risks: the EMA undertook an in-depth review of the issue …

via natlawreview04/12/2021

Transatlantic Trade US and Europe – April 5, 2021 - The National Law Review

Transatlantic trade report for the week of April 5, 2021 including COVID-19 developments with respect to the EU, UK, US; An update related to the EU COVID-19 vaccine export control mechanism; UK-EU trade deal developments; and US sanctions with respect to Burma, China, and the Western Hemisphere.

via laprensalatina04/10/2021

Artists occupy Belgium opera house to protest Covid restrictions on culture - La Prensa Latina

Brussels, Apr 10 (EFE).- A group of artists has occupied the national opera house in Brussels to highlight the plight of the culture sector in the face of Covid-19 restrictions, which have closed down theaters and cinemas across Belgium. The Royal Theatre of La Monnaie was first built in the early 1700s, although has had …


Belgian swans released after months of their own virus lockdown - Yahoo News Canada

Belgian authorities today (April 7) released 120 swans that have been in lockdown for more than four months due to an outbreak of bird flu. The wild birds were taken from the canals of the picturesque city of Bruges in mid-November and transported to other parts of the country for their own safety after the virus was detected in the city of Ostend. Authorities brought the birds back to Bruges in lorries and carefully released them on the grassy bank of a canal. After more than four months away from home, the birds waddled immediately down to the water and jumped in, seemingly delighted to be back in the famous canals of the medieval city.

via schengenvisainfo04/06/2021

Lithuania Imposes Stricter Entry Rules for Arrivals From Belgium & the Netherlands - -

The Lithuanian Government has added Belgium, Netherlands, Bosnia and Herzegovina, Moldova, Bermuda, and Curacao to the list of highly affected COVID-19 countries due to their increased number of reported cases. On the other hand, the Government announced that Malta will no longer be part of the same list, reports. In a press release issued […]

via schengenvisainfo04/05/2021

Czechia Adds Belgium & Netherlands to High-Risk COVID-19 Category - -

The Czech Republic’s government has announced that from April 5, Belgium and the Netherlands will be included on the COVID-19 dark red list, in which are placed countries profoundly affected by the Coronavirus disease. At the same time, Ireland and Malta will be placed on the red list of countries, while Iceland will move to […]

via theloadstar04/14/2021

A new state-of-the-art 50,000-m² logistics building at Brussels Airport -

Brussels Airport, 12 April 2021 A new state-of-the-art 50,000-m² logistics building at Brussels Airport After two years of construction work, a new logistics building for the handling of goods was officially opened in the logistics area at Brussels Airport. This building which provides large refrigerated storage spaces and offers direct airside access, henceforth accommodates three first-class logistics companies: Kuehne+Nagel, Worldwide Flight Services and Expeditors. Brussels Airport boasts an essential logistics platform ...

via news.yahoo04/13/2021

Belgium to continue with Johnson & Johnson vaccine for the time being - Yahoo News

Belgium will continue COVID-19 vaccinations with the Johnson & Johnson jab for the moment, a spokesperson for the Belgian vaccination task force told Belga news agency on Tuesday. "At this time, we have not received any signals that we should stop the vaccination," said Gudrun Briat, a spokesperson for the vaccination task force. Belgium received 36,000 doses of the Johnson & Johnson jab yesterday.

via news.yahoo04/09/2021

Brown bears come out of hibernation at Belgian zoo - Yahoo News

A caretaker at Domaine des Grottes de Han, a wildlife park specialized in European animals, Valerian Boudart said the large carnivores had lost weight during their three to four-month-long hibernation and would spend the summer trying to regain strength before the winter.Boudart sought to clear up a common misconception by explaining that hibernation was not synonymous with continuous sleep."They do not sleep continuously for three or four months. They do so in small phases. They remain attentive to all external noises," he said.Found across North America and Eurasia, brown bears thrive in certain areas such as Scandinavia, Russia, Canada and the northern United States.They are classified as least concern, according to the International Union for Conservation of Nature and Natural Resources.

via voanews04/08/2021

COVID-19 Prompts Rethink of European Populist Tactics - Voice of America

Euro-skeptic populist leaders are adjusting political tactics — instead of calling for their countries to follow Britain and quit the European Union, they’re focusing now on changing the bloc from within.  “I think after the COVID crisis, the EU needs to reinvent itself and find a new soul,” Matteo Salvini, leader of Italy’s Lega party and a former Italian deputy prime minister, told the New Europe newspaper.

via wionews04/06/2021

CDC says young people are driving pandemic surge - WION

A top public health official said young people are driving the latest uptick in COVID-19 cases, as the increasing rate of vaccination in older Americans prevents the most serious cases among seniors. Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, cited the increasing spread of variants as well as a rise in youth sports and extracurricular activities as factors contributing to the steady increase in cases over the last four weeks.

via wbng04/06/2021

Easter weekend brings Belgium another record cocaine seizure - WBNG-TV

BRUSSELS (AP) — Belgian authorities came out of the long Easter weekend with another record cocaine haul after customs officials at the port of Antwerp seized almost 11 tons of the drug that was discovered amid a cargo of blue leather. Prosecutors said the shipment brought the total amount of cocaine seized in Belgium over

via voanews04/04/2021

New Coronavirus Cases Put Mumbai in Lockdown - Voice of America

India’s health ministry said Sunday that it recorded 93,249 new coronavirus cases in the previous 24-hour period, the highest daily tally this year in the South Asian nation. Mumbai, India’s financial capital and the capital of Maharashtra state, is now under stringent lockdown measures. Half of the country’s new cases of the virus have been recorded in that state.  Nawab Malik, a minister in the state government, told reporters that a nightly curfew from 8 p.m. to 7 a.m. local time would be imposed starting Monday.

via finance.yahoo04/13/2021

Press release Biocartis Group NV: Invitation to the Annual and Extraordinary Shareholders’ Meetings - Yahoo Finance

PRESS RELEASE: REGULATED INFORMATION 13 April 2021, 07:00 CEST Invitation to the Annual and Extraordinary Shareholders’ Meetings Mechelen, Belgium, 13 April 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), has the honor to invite its shareholders, holders of subscription rights, holders of convertible bonds, directors and statutory auditor to its annual and extraordinary shareholders' meetings that will be held on Friday 14 May 2021 at 2:00 p.m. CEST. In light of the COVID-19 pandemic, it is currently envisaged that the measures imposed by the Belgian government to deal with this pandemic, such as the limitations on the number of people attending gatherings and the obligation to guarantee a distance of 1.5 meters between each person, may still be in effect on 14 May 2021, the date of the Company's annual and extraordinary shareholders' meetings. These measures are in the interest of the health of individual securities holders, as well as of the employees of the Company and others who are responsible for organizing the shareholders' meetings. Furthermore, it cannot be excluded that the Belgian government will impose additional measures. As a result, the Company advises its securities holders not to attend the annual and extraordinary shareholders' meetings in person. Shareholders can exercise their voting rights by voting by mail form or by written proxy to the chairman of the Board of Directors of the Company. The Company will also set up a video conference to allow those holders of securities of the Company who have duly registered for the annual and extraordinary shareholders’ meetings and who have duly completed and returned the form ‘Attendance Form for Securities Holders’ to the Company to follow the meeting remotely and ask questions during the meetings. The video conference will not qualify as an electronic communication tool to attend and vote at the shareholders' meetings in the meaning of Article 7:137 of the Belgian Code of Companies and Associations, but will be an extra facility for securities holders to follow the shareholders' meetings. Furthermore, the Company recommends its securities holders to exercise their right to ask questions with respect to the agenda items of the shareholders' meetings in writing, before the shareholders' meetings. More information about voting by mail or by written proxy and exercising the right to ask questions can be found in the convening notice. Biocartis will monitor the COVID-19 situation closely and will disclose all relevant information and measures that have an impact on the shareholders' meetings on the Biocartis website. Depending on the situation and the possibilities provided for by the applicable legislation, the Company reserves the right to take additional measures. The Board of Directors would like to thank the securities holders for their understanding and cooperation. In order to be admitted to the shareholders’ meetings, the holders of securities issued by the Company must comply with Article 7:134 of the Belgian Code of Companies and Associations and the articles of association of the Company, and fulfill the formalities described in the convening notice. The convening notice and other documents relating to the shareholders’ meetings can be consulted on the Company’s website. --- END --- More information: Renate Degrave Head of Corporate Communications & Investor Relations Biocartis e-mail tel +32 15 631 729 mobile +32 471 53 60 64 About Biocartis Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Biocartis' proprietary MDx Idylla™ platform is a fully automated sample-to-result, real-time PCR (Polymerase Chain Reaction) system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting. Biocartis is developing and marketing a continuously expanding test menu addressing key unmet clinical needs, with a focus in oncology, which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as for SARS-CoV-2 and sepsis. More information: Follow us on Twitter: @Biocartis_. Biocartis and Idylla™ are registered trademarks in Europe, the United States and other countries. The Biocartis and Idylla™ trademark and logo are used trademarks owned by Biocartis. Please refer to the product labeling for applicable intended uses for each individual Biocartis product. This press release is not for distribution, directly or indirectly, in any jurisdiction where to do so would be unlawful. Any persons reading this press release should inform themselves of and observe any such restrictions. Biocartis takes no responsibility for any violation of any such restrictions by any person. This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction. No securities of Biocartis may be offered or sold in the United States of America absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended. Forward-looking statementsCertain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' or managements' current expectations and projections concerning future events such as the Company's results of operations, financial condition, liquidity, performance, prospects, growth, strategies and the industry in which the Company operates. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

via republicworld04/10/2021

COVID-19: From France to Poland, list of countries that have re-imposed lockdown - Republic TV

Stay informed with today’s latest news from India & around the world. Get all the breaking news & current Indian news on politics, sports and entertainment only on Republic World. We provide the most in-depth coverage of top national news with timely breaking of all the recent news on politics, sports & entertainment

via finance.yahoo04/09/2021

Ureteroscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) - Yahoo Finance

Summary Ureteroscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area.New York, April 09, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Ureteroscopes (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - The model discusses in detail the impact of COVID-19 on Ureteroscopes market for the year 2020 and beyond. The ureteroscopes market is driven by a variety of factors, including a growing aging population, increase in patients with kidney stones, and other conditions of the kidney, ureter, and bladder.The global population with urological disorders continues to increase with more than 200 million people worldwide estimated to have kidney disorders.Ureteroscopes are devices used to administer medication to these patients.This rising number of patients with urological disorders is expect to result in a larger number of hospitals that require ureteroscopes, resulting in an increase in the market for ureteroscopes.Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).Moreover, analyst comments with qualitative insight offer context for quantitative data.Key Inclusions of the market model are -Currently marketed Ureteroscopes and evolving competitive landscape -- Insightful review of the key industry trends.- Annualized total Ureteroscopes market revenue by segment and market outlooks from 2015-2030.- Granular data on total installed base, units, average selling prices and market values by segment.Global, Regional and Country level market specific insights -- Qualitative market specific information is available with global trends further broken down into regional trends. In addition analysts provide unique country specific insights on the market.- SWOT analysis for Ureteroscopes market.- Competitive dynamics insights and trends provided for Ureteroscopes market.Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.- Country specific overview of the healthcare system.- Country specific reimbursement policies.- Country specific medtech regulatory landscape.Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.Companies covered: KARL STORZ GmbH & Co KG, Hoya Corp , Olympus Corp, Boston Scientific, Richard Wolf GmbH, Stryker Corp and OthersCountries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.ScopeThis Market Model gives important, expert insight you won’t find in any other source.The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -- CMO executives who must have deep understanding of the Ureteroscopes marketplace to make strategic planning and investment decisions.- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.Reasons to BuyThe model will enable you to -- Understand the impact of COVID-19 on Ureteroscopes market.- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving Ureteroscopes market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Ureteroscopes market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Track device sales in the global and country-specific Ureteroscopes market from 2015-2030.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001

via reuters04/07/2021

Fact Check-Video does not show the Belgian health minister faking his COVID-19 jab - Reuters

Social media users have falsely claimed a video shows Belgian Health Minister Frank Vandenbroucke pretending to receive the coronavirus vaccine to “encourage compliance”. While the clip does show a Flemish minister, it is not Vandenbroucke – nor was the minister supposed...

via republicworld04/06/2021

Belgium authorities say ICU patients to pass 1,000 - Republic World

Stay informed with today’s latest news from India & around the world. Get all the breaking news & current Indian news on politics, sports and entertainment only on Republic World. We provide the most in-depth coverage of top national news with timely breaking of all the recent news on politics, sports & entertainment

via menafn04/05/2021

Belgium records over 900000 COVID-19 cases - MENAFN.COM

A total of 900,996 people have tested positive for coronavirus in Belgium, official figures published on Monday by the Sciensano public health institute showed, Trend reports citing Xinhua.

Belgium, with a population of more than 11 million, has recorded a total of 23,169 deaths since the beginning of the pandemic.

Since April 1, Belgium has